Last reviewed · How we verify
Stiptanon (estriol succinate)
Stiptanon (generic name: estriol succinate) is a estriol succinate drug. It is currently in unknown development.
Stiptanon works by binding to estrogen receptors, specifically the beta subtype, to exert its effects.
Stiptanon, also known as estriol succinate, is a small molecule that targets the estrogen receptor beta. It is classified as an estriol succinate and its mechanism of action involves binding to estrogen receptors, specifically beta receptors. However, due to the lack of available information, its commercial status, approved indications, half-life, bioavailability, and generic manufacturers are unknown. As a result, its clinical use and safety profile are also unclear. Further research is needed to determine the potential benefits and risks of Stiptanon.
At a glance
| Generic name | estriol succinate |
|---|---|
| Drug class | estriol succinate |
| Target | Corticosteroid-binding globulin, Olfactory receptor 51E2, Alpha-synuclein |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Think of estrogen receptors like locks on a door. Estriol succinate, or Stiptanon, is a key that fits into these locks, specifically the beta subtype. When it binds, it can turn on or off certain genes that control how cells grow and function.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Stiptanon CI brief — competitive landscape report
- Stiptanon updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Stiptanon
What is Stiptanon?
How does Stiptanon work?
What is the generic name of Stiptanon?
What drug class is Stiptanon in?
What development phase is Stiptanon in?
What does Stiptanon target?
Related
- Drug class: All estriol succinate drugs
- Target: All drugs targeting Corticosteroid-binding globulin, Olfactory receptor 51E2, Alpha-synuclein
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing